Vitamin D in pregnancy and infancy : dietary sources and associations with pregnancy outcomes and infant growth
Helena Hauta-alus
HUS Lasten ja nuorten sairaudetLastenklinikkaDoctoral Programme in Clinical ResearchHelsingin yliopisto
Tutkimustuotos: Opinnäyte › Väitöskirja
Pregnancy category starts with
- see also
- Overview Pregnancy and vitamin D
- Number of articles in both categories of Pregnancy and:Dark Skin
25 ; Depression 20 ; Diabetes 42 ; Obesity 14 ; Hypertension 40 ; Breathing 31 ; Omega-3 39 ; Vitamin D Receptor 22 Click here for details - All items in category Infant/Child
735 items - Pregnancy needs at least 40 ng of vitamin D, achieved by at least 4,000 IU – Hollis Aug 2017
- 34 papers with Breastfeeding of Breastfed in title as of Jan 2022
- Preeclampsia in Vitamin D Life title (52 as of Aug 2022)
- PRETERM or PREEMIE: contained by 100 titles as of Feb 2022
- "polycystic ovary syndrome" OR PCOS 303 items as of Jan 2018
- Gestational Diabetes
- c-section OR "caesarean section" (various spellings) 937 items as of Aug 2020
- postpartum depression 208 items as of Aug 2018
- 31 Vitamin D Life pages had MISCARRIAGE in title as of Aug 2022
- Search Vitamin D Life for "Assisted reproduction" 33 items as of Aug 2022
- Fertility and Sperm category listing has
127 items along with related searches - (Stunting OR “low birth weight” OR LBW) 1180 items as of June 2020
- Less labor pain if higher level of vitamin D – August 2021
- Healthy pregnancies need lots of vitamin D
- Ensure a healthy pregnancy and baby - take Vitamin D before conception
Healthy pregnancies need lots of vitamin D has the following summary
ProblemReduces Evidence 0. Chance of not conceiving 3.4 times Observe 1. Miscarriage 2.5 times Observe 2. Pre-eclampsia 3.6 times RCT 3. Gestational Diabetes 3 times RCT 4. Good 2nd trimester sleep quality 3.5 times Observe 5. Premature birth 2 times RCT 6. C-section - unplanned 1.6 times Observe Stillbirth - OMEGA-3 4 times RCT - Omega-3 7. Depression AFTER pregnancy 1.4 times RCT 8. Small for Gestational Age 1.6 times meta-analysis 9. Infant height, weight, head size
within normal limitsRCT 10. Childhood Wheezing 1.3 times RCT 11. Additional child is Autistic 4 times Intervention 12.Young adult Multiple Sclerosis 1.9 times Observe 13. Preeclampsia in young adult 3.5 times RCT 14. Good motor skills @ age 3 1.4 times Observe 15. Childhood Mite allergy 5 times RCT 16. Childhood Respiratory Tract visits 2.5 times RCT RCT = Randomized Controlled Trial
 Download the PDF from Vitamin D Life
Kuvaus
Vitamin D is vital for normal growth and development. Vitamin D is produced endogenously in the skin after sunlight exposure or obtained from dietary sources. In Finland, solar radiation is inadequate for cutaneous vitamin D synthesis in winter, leading to a high risk for vitamin D insufficiency, defined by circulating 25-hydroxyvitamin D concentration [25(OH)D] below 50 nmol/l. Poor maternal 25(OH)D has been associated with adverse pregnancy and neonatal outcomes, such as pre-eclampsia, gestational diabetes mellitus (GDM), and low birth weight. Only a few studies have explored the relationship between vitamin D and infant postnatal growth, and these studies show inconsistent results. Further, data on current maternal vitamin D status and infant vitamin D intake in Finland are lacking. The objectives of this thesis were to- 1) define maternal and newborn 25(OH)D concentrations and characterize maternal determinants of vitamin D status during pregnancy;
- 2) examine whether vitamin D status differs between mothers with and without GDM;
- 3) describe vitamin D intake from food and identify food sources of vitamin D in 1-year-old infants, and finally,
- 4) investigate whether maternal or infant vitamin D status associate with pre- and postnatal infant growth.
This thesis is part of the Vitamin D Intervention in Infants (VIDI) study. At Helsinki Maternity Hospital, 987 families were recruited to the study from January 2013 to June 2014.
Title change made April 2022 caused the visitor count to reset.
Infants were randomized to daily supplemental vitamin D dosages of 10 µg or 30 µg from 2 weeks until 2 years of age.
Mothers were of Northern European ethnicity without regular medication. Infants were born at term with birth weights appropriate for gestational age. Maternal serum samples were collected at prenatal clinics between 2012 and 2013 in early pregnancy. At birth, umbilical cord blood (UCB) was obtained. Circulating 25(OH)D was analyzed with IDS-iSYS from pregnancy, UCB and infant serum samples at 1 year of age. Maternal dietary patterns were derived from a 22-item food frequency questionnaire and infant vitamin D intake was assessed with a 3-day food record. GDM diagnosis and data on infant birth size were obtained from medical records. Infant growth was measured at study visits at the ages of 6 months and 1 year.
Overall, the pregnant women and their newborns were vitamin D sufficient as the concentration of 25(OH)D in 96% of all subjects was ≥50 nmol/l.
Of pregnant women, 95% used vitamin D supplements with a mean daily intake of 16 µg. Maternal positive predictors of 25(OH)D during pregnancy, based on 25(OH)D from early pregnancy to UCB, were supplemental vitamin D intake, a dietary pattern characterized by regular use of vitamin D–fortified foods and prepregnancy physical activity. In contrast, factors associating with declining 25(OH)D during pregnancy were smoking and multiparity. GDM was observed in 11% of the pregnant women. Maternal 25(OH)D concentrations did not differ between GDM and non-GDM women. Furthermore, 25(OH)D had no relation to oral glucose tolerance test results. Mean daily intake of vitamin D from food was 7.5 µg in non-breastfed and 3.8 µg in breastfed 1-year-old infants. The main food sources of vitamin D were infant formula, dairy milk, porridge, and fish foods. Higher maternal and infant 25(OH)D were associated with slower infant growth. At 6 months of age, infants to mothers with high pregnancy 25(OH)D (>125 nmol/l) were the shortest (in length), lightest (in weight), and thinnest (in length-adjusted weight). Higher UCB 25(OH)D had an inverse association with head circumference at birth and infant length at 6 months. In infants, higher UCB 25(OH)D associated with slower linear growth from birth to 6 months, but an accelerated growth from 6 months to 1 year of age. Infants with 25(OH)D >125 nmol/l were the lightest and thinnest at 1 year of age, whereas mothers with UCB 25(OH)D <50 nmol/l had the thinnest infants at 6 months.
In conclusion, vitamin D status was sufficient among pregnant women in Finland. Likewise, infants who participated in a vitamin D supplementation trial had sufficient vitamin D status at 1 year of age. High maternal and infant 25(OH)D associated with slower infant growth. These results may indicate a
possible inverse U-shaped relationship between vitamin D status and growth. The clinical relevance of this finding remains unknown. Until more data emerge, there is no need to aim for higher maternal or infant 25(OH)D concentrations beyond vitamin D sufficiency with excessive supplementation as this may have disadvantageous effects on infant growth.
There have actually beenPlugin execution pending approval
This plugin was recently added or modified. Until an editor of the site validates the parameters, execution will not be possible.
95 percent of pregnant women in Finland took vitamin D – PHD Dissertation Dec 2019530 visitors, last modified 04 Apr, 2022, This page is in the following categories (# of items in each category) - All items in category Infant/Child